Free from Publisher

Palliation and survival after repeated 188Re-HEDP therapy of hormone-refractory bone metastases of prostate cancer: a retrospective analysis

F Orsini, F Guidoccio, S Mazzarri… - Journal of Nuclear …, 2012 - Soc Nuclear Med
1. Van Nostrand D, Khorjekar GR, O'Neil J, et al. Recombinant human thyroidstimulating
hormone versus thyroid hormone withdrawal in the identification of metastasis in …
被引用次数：5 相关文章

Again, I thank Schneider et al. for their compliments, comments, and time.

C Schneider, D Kahraman, C Kobe - cancer. J, 2006 - Soc Nuclear Med
1. Van Nostrand D, Khorjekar GR, O'Neil J, et al. Recombinant human thyroidstimulating
hormone versus thyroid hormone withdrawal in the identification of metastasis in …

Palliation and Survival After Repeated^ sup 188^ Re-HEDP Therapy of Hormone-Refractory Bone Metastases of Prostate Cancer: A Retrospective Analysis

F Orsini, F Guidoccio, S Mazzarri… - The Journal of …, 2012 - search.proquest.com
Because our group shares with the authors a similar interest in the potentials of therapeutic
bone-seeking radiopharmaceuticals not only for palliation of bone pain but also for some …

[引用][C] Palliation and survival after repeated 188Re-HEDP therapy of hormone-refractory bone metastases of prostate cancer: a retrospective analysis

F Orsini, F Guidoccio, S Mazzarri… - Journal of nuclear …, 2012 - pubmed.ncbi.nlm.nih.gov
Palliation and survival after repeated 188Re-HEDP therapy of hormone-refractory bone
metastases of prostate cancer: a retrospective analysis Palliation and survival after repeated …

[引用][C] Palliation and survival after repeated 188Re-HEDP therapy of hormone-refractory bone metastases of prostate cancer: a retrospective analysis.

F Orsini, F Guidoccio, S Mazzarri… - Journal of Nuclear …, 2012 - europepmc.org
Palliation and survival after repeated 188Re-HEDP therapy of hormone-refractory bone
metastases of prostate cancer: a retrospective analysis. - Abstract - Europe PMC Sign in | Create …